Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis

被引：0
|
作者：
Sato, Takeo [1 ]
Inokuma, Shigeko [1 ]
机构：
[1] Japanese Red Cross Med Ctr, Dept Allerg Dis & Rheumatol, Shibuya Ku, Tokyo 1508935, Japan
来源：
RHEUMATOLOGY | 2010年 / 49卷 / 08期
关键词：
D O I：
10.1093/rheumatology/keq106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1607 / 1607
页数：1
相关论文
共 50 条
  • [11] A 12-month open-label trial of mycophenolate mofetil in multiple sclerosis
    Gogovska, L
    Ljapcev, R
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S263 - S264
  • [12] Mycophenolate mofetil for the treatment of systemic sclerosis
    Naik, Manisha
    Shenin, Max
    Derk, Chris T.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (02) : 134 - 136
  • [13] Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy - An open-label study
    Radziwill, A. J.
    Schweikert, K.
    Kuntzer, T.
    Fuhr, P.
    Steck, A. J.
    EUROPEAN NEUROLOGY, 2006, 56 (01) : 37 - 38
  • [14] Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
    Smith, V.
    Van Praet, J. T.
    Vandooren, B.
    Van der Cruyssen, B.
    Naeyaert, J-M
    Decuman, S.
    Elewaut, D.
    De Keyser, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 193 - 197
  • [15] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
    Denton, C. P.
    Engelhart, M.
    Tvede, N.
    Wilson, H.
    Khan, K.
    Shiwen, X.
    Carreira, P. E.
    Gonzalez, F. Diaz
    Black, C. M.
    van den Hoogen, F. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) : 1433 - 1439
  • [16] Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open-label pilot study
    Bishnoi, Anuradha
    Vinay, Keshavamurthy
    Parsad, Davinder
    Kumar, Sheetanshu
    Chatterjee, Debajyoti
    Saikia, Uma Nahar
    Kumaran, Muthu Sendhil
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : 278 - 285
  • [17] Mycophenolate mofetil in diffuse cutaneous systemic sclerosis - a retrospective analysis
    Nihtyanova, S. I.
    Brough, G. M.
    Black, C. M.
    Denton, C. P.
    RHEUMATOLOGY, 2007, 46 (03) : 442 - 445
  • [18] An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
    Denton, Christopher P.
    Engelhart, Merete
    Tvede, N.
    Khan, Korsa
    Carreire, Patricia E.
    Gonzalez, F. Diaz
    Van den Hoogen, Frank H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S524 - S524
  • [19] MYCOPHENOLATE MOFETIL AS SECOND LINE IMMUNOSUPPRESSANT IN MYASTHENIA GRAVIS - A LONG-TERM PROSPECTIVE OPEN-LABEL STUDY
    Hanisch, F.
    Wendt, M.
    Zierz, S.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (08) : 364 - 366
  • [20] Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
    F Hanisch
    M Wendt
    S Zierz
    European Journal of Medical Research, 14
12345